Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
INP
iPath ETNs Linked to the MSCI India Total Return Index
INP
|
+$1.36B |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$236M |
| 3 |
Apple
AAPL
|
+$223M |
| 4 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$222M |
| 5 |
Southern Company
SO
|
+$182M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
FON
SPRINT CORP FON COM
FON
|
+$724M |
| 2 |
Pfizer
PFE
|
+$469M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$409M |
| 4 |
iShares US Real Estate ETF
IYR
|
+$407M |
| 5 |
Zoetis
ZTS
|
+$215M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 4.63% |
| 2 | Healthcare | 4.25% |
| 3 | Technology | 4.18% |
| 4 | Energy | 3.42% |
| 5 | Communication Services | 3.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ANR
2376
CALL
DELISTED
Alpha Natural Resources Inc
ANR
| $2.31M | ﹤0.01% |
462,100
+86,200
| +23% | +$505K |
|
2377
PUT
Murphy Oil
MUR
$5.09B
| $2.31M | ﹤0.01% |
38,500
-30,054
| -44% | -$1.77M |
|
2378
Gentex
GNTX
$5.02B
| $2.31M | ﹤0.01% |
184,692
-123,504
| -40% | -$1.46M |
|
2379
PUT
State Street SPDR S&P Regional Banking ETF
KRE
$4.56B
| $2.3M | ﹤0.01% |
65,800
+41,100
| +166% | +$1.48M |
|
|
ACH
2380
Accendra Health
ACH
$107M
| $2.3M | ﹤0.01% |
67,662
+33,406
| +98% | +$1.17M |
|
2381
CALL
Charles River Laboratories
CRL
$13.2B
| $2.3M | ﹤0.01% |
+50,000
| New | +$2.29M |
|
|
2382
PUT
Charles River Laboratories
CRL
$13.2B
| $2.3M | ﹤0.01% |
+50,000
| New | +$2.29M |
|
2383
Maximus
MMS
$2.9B
| $2.3M | ﹤0.01% |
51,089
-24,475
| -32% | -$947K |
|
|
MRC
2384
DELISTED
MRC Global
MRC
| $2.3M | ﹤0.01% |
88,437
+36,605
| +71% | +$975K |
|
2385
PUT
CACI
CACI
$14.3B
| $2.3M | ﹤0.01% |
33,300
+22,100
| +197% | +$1.48M |
|
2386
ProShares Ultra Russell2000
UWM
$243M
| $2.3M | ﹤0.01% |
127,672
-62,040
| -33% | -$1.06M |
|
2387
PUT
iShares Select Dividend ETF
DVY
$23.6B
| $2.29M | ﹤0.01% |
34,700
+17,100
| +97% | +$1.14M |
|
2388
CALL
State Street SPDR Bloomberg High Yield Bond ETF
JNK
$7.3B
| $2.29M | ﹤0.01% |
19,567
+13,434
| +219% | +$1.61M |
|
|
KATE
2389
DELISTED
Kate Spade & Company
KATE
| $2.29M | ﹤0.01% |
91,396
-24,546
| -21% | -$598K |
|
|
TCP
2390
DELISTED
TC Pipelines LP
TCP
| $2.28M | ﹤0.01% |
47,593
+8,381
| +21% | +$414K |
|
2391
Commault Systems
CVLT
$5.78B
| $2.28M | ﹤0.01% |
26,243
+17,662
| +206% | +$1.48M |
|
|
UPL
2392
PUT
DELISTED
Ultra Petroleum Corp. Common Stock
UPL
| $2.28M | ﹤0.01% |
113,900
+29,900
| +36% | +$629K |
|
|
MAKO
2393
PUT
DELISTED
MAKO SURGICAL CORP COM
MAKO
| $2.28M | ﹤0.01% |
78,500
+23,100
| +42% | +$352K |
|
2394
Emcor
EME
$35.7B
| $2.27M | ﹤0.01% |
58,235
-18,837
| -24% | -$763K |
|
|
SGI
2395
CALL
Somnigroup International
SGI
$13.6B
| $2.27M | ﹤0.01% |
211,200
+74,400
| +54% | +$772K |
|
|
INVN
2396
CALL
DELISTED
Invensense Inc
INVN
| $2.27M | ﹤0.01% |
133,500
+92,700
| +227% | +$1.57M |
|
2397
PUT
Boston Properties
BXP
$10.8B
| $2.27M | ﹤0.01% |
21,400
-7,100
| -25% | -$751K |
|
|
PETM
2398
PUT
DELISTED
PETSMART INC
PETM
| $2.27M | ﹤0.01% |
29,800
-7,100
| -19% | -$513K |
|
|
RGC
2399
DELISTED
Regal Entertainment Group
RGC
| $2.26M | ﹤0.01% |
125,737
-18,068
| -13% | -$338K |
|
2400
PUT
Acadia Pharmaceuticals
ACAD
$5.06B
| $2.26M | ﹤0.01% |
83,800
-19,400
| -19% | -$406K |
|
Similar funds
Barclays's Q3 2013 Portfolio in Review
As of Q3 2013, Barclays held 8,017 positions worth $83.8B, up 4.2% from $80.4B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Barclays's Q3 2013 filing shows 302 new, 3,328 increased, 3,470 reduced and 580 closed positions. Its largest new stake was Twenty-First Century Fox, Inc. Class A: 2,167,568 shares worth $71.5M. The largest sale was SPRINT CORP FON COM, an estimated $724M.
By sector, the portfolio is most concentrated in Financials at 4.6% of assets, up from 4.5% a quarter earlier, followed by Healthcare and Technology.
- Barclays's largest Q3 2013 buy was Twenty-First Century Fox, Inc. Class A: 2,167,568 shares worth $71.5M.
- Barclays added most to iPath ETNs Linked to the MSCI India Total Return Index in Q3 2013, an estimated $1.36B increase.
- Barclays's biggest Q3 2013 reduction was Pfizer, cutting an estimated $469M.
- Barclays fully exited SPRINT CORP FON COM in Q3 2013, selling an estimated $724M.
- Barclays's ten largest holdings make up 26% of its $83.8B portfolio in Q3 2013.
- Barclays opened 302 new positions and closed 580 in Q3 2013.
- Barclays's portfolio value rose 4.2% quarter-over-quarter to $83.8B.
Based on Barclays's 13F filing for Q3 2013, filed 14 Nov 2013.